Clinical Trials · NCT05895643
Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity?
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Psychiatric Centre Rigshospitalet
- Enrollment
- 108
- Start date
- Jun 2023
- Locations
- 1 site, Denmark
- Primary endpoint
- Change in heavy drinking days